Cancer subtyping with heterogeneous multi-omics data via hierarchical multi -kernel learning

Differentiating cancer subtypes is crucial to guide personalized treatment and improve the prognosis for patients. Integrating multiomics data can offer a comprehensive landscape of cancer biological process and provide promising ways for cancer diagnosis and treatment. Taking the heterogeneity of different omics data types into account, we propose a hierarchical multi -kernel learning (hMKL) approach, a novel cancer molecular subtyping method to identify cancer subtypes by adopting a two -stage kernel learning strategy. In stage 1, we obtain a composite kernel borrowing the cancer integration via multi -kernel learning (CIMLR) idea by optimizing the kernel parameters for individual omics data type. In stage 2, we obtain a final fused kernel through a weighted linear combination of individual kernels learned from stage 1 using an unsupervised multiple kernel learning method. Based on the final fusion kernel, k -means clustering is applied to identify cancer subtypes. Simulation studies show that hMKL outperforms the one -stage CIMLR method when there is data heterogeneity. hMKL can estimate the number of clusters correctly, which is the key challenge in subtyping. Application to two real data sets shows that hMKL identified meaningful subtypes and key cancer-associated biomarkers. The proposed method provides a novel toolkit for heterogeneous multi-omics data integration and cancer subtypes identification.